LSD-POTENTIATED APOMORPHINE HYPERMOTILITY - A MODEL FOR DIFFERENTIATING ANTI-PSYCHOTIC DRUGS

被引:16
作者
MORGENSTERN, R
FINK, H
OELSSNER, W
机构
关键词
D O I
10.1016/0091-3057(83)90243-5
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
引用
收藏
页码:13 / 17
页数:5
相关论文
共 47 条
[11]   BEHAVIORAL-EFFECTS OF DOPAMINE APPLIED INTRACEREBRALLY TO AREAS OF MESOLIMBIC SYSTEM [J].
COSTALL, B ;
NAYLOR, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 32 (01) :87-92
[12]   NEUROLEPTIC ANTAGONISM OF THE MOTOR INHIBITORY EFFECTS OF APOMORPHINE WITHIN THE NUCLEUS ACCUMBENS - DRUG-INTERACTION AT PRESYNAPTIC RECEPTORS [J].
COSTALL, B ;
FORTUNE, DH ;
HUI, SC ;
NAYLOR, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1980, 63 (04) :347-358
[13]   MESOLIMBIC INVOLVEMENT WITH BEHAVIORAL-EFFECTS INDICATING ANTIPSYCHOTIC ACTIVITY [J].
COSTALL, B ;
NAYLOR, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 27 (01) :46-58
[14]   ANTAGONISM OF HYPERACTIVITY INDUCED BY DOPAMINE APPLIED INTRACEREBRALLY TO NUCLEUS ACCUMBENS SEPTI BY TYPICAL NEUROLEPTICS AND BY CLOZAPINE, SULPIRIDE AND THIORIDAZINE [J].
COSTALL, B ;
NAYLOR, RJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 35 (01) :161-168
[15]  
CROW TJ, 1975, BRIT J PHARMACOL, V55, pP295
[16]  
DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V62, P1
[17]   PSYCHOTOMIMETICS POTENTIATE LOCOMOTOR HYPERACTIVITY INDUCED BY DOPAMINERGIC DRUGS [J].
FINK, H ;
MORGENSTERN, R ;
OELSSNER, W .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1979, 11 (05) :479-482
[18]  
FINK H, 1980, ACTA BIOL MED GER, V39, P903
[19]   LSD, MESCALINE AND SEROTONIN INJECTED INTO MEDIAL RAPHE NUCLEUS POTENTIATE APOMORPHINE HYPERMOTILITY [J].
FINK, H ;
OELSSNER, W .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1981, 75 (04) :289-296
[20]   BEHAVIORAL-STUDIES FOLLOWING LESIONS OF MESOLIMBIC AND MESOSTRIATAL SEROTONERGIC PATHWAYS [J].
GEYER, MA ;
PUERTO, A ;
MENKES, DB ;
SEGAL, DS ;
MANDELL, AJ .
BRAIN RESEARCH, 1976, 106 (02) :257-270